ArticleFrontiers in oncology2025

The clinical validity of radiomics-based prediction of molecular subtypes in breast cancer from digital mammary tomosynthesis.

Jing Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.